C‐reactive protein variability is associated with vascular access outcome in hemodialysis patients. Issue 1 (27th April 2017)

• Record Type: Journal Article
• Authors: Kuo, Wei‐Hung; Lee, Yueh‐Ting; Ng, Hwee‐Yeong; Wang, Chun‐Yeh; Wu, Chien‐Hsing; Lee, Chien‐Te
• Is Part Of: Journal of clinical laboratory analysis. Volume 32:Issue 1(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2017-04-27
• Subjects: C‐reactive protein -- hemodialysis -- vascular access; Diagnosis, Laboratory -- Periodicals; Medical laboratory technology -- Periodicals; 616
• DOI: 10.1002/jcla.22213
• Languages: English
• ISSNs: 0887-8013

Abstract

Abstract : Background: Hemodialysis (HD) vascular access failure is one of the most important causes of morbidity and contributes to the cost of dialysis care. There is paucity of data evaluating long‐term monitoring of C‐reactive protein (CRP) on outcome of HD vascular access. Methods: We conducted a retrospective study to investigate whether variability of serum CRP level was associated with vascular access failure rate over a 7‐year period. A total of 318 HD patients were included. Their demographic data, co‐morbidities and biochemical data were reviewed and collected. Serum high‐sensitivity CRP (hs‐CRP) level was measured every 6 months. Patients were divided into three groups according to their serial hs‐CRP levels. Patients with their hs‐CRP below 2 mg/L were defined as low group (n=65, 20.4%) and those with higher than 4 mg/L were defined as high (n=39, 12.3%). The rest were classified as fluctuated hs‐CRP group (n=214, 67.3%). Treatment of vascular access failure includes angioplasty and access re‐creation. Results: Their body mass index, indicators of dialysis adequacy and serum albumin and hs‐CRP levels differed significantly among three groups. The annual vascular access failure rate was significantly higher in fluctuated hs‐CRP group than in high hs‐CRP group (0.41 vs 0.36, P =.037). Serum albumin was a significant associate of vascular access failure. Kaplan‐Meier survival analysis indicated patients with high or fluctuated hs‐CRP had shorter free interval of vascular access failure than low hs‐CRP group. Conclusions: HD patients with fluctuated hs‐CRP levels were associated with increased vascular access failure.